SEC 13F Intelligence

Aperio Group, LLC / ABT

Aperio Group, LLC’s Abbott Laboratories Position

Does Aperio Group, LLC own Abbott Laboratories (ABT)? Yes — 1.53M shares worth $168M (+0.50% of its 13F portfolio) as of Q4 2020, up from 1.51M shares the prior filed quarter.

Position Value
$168M
Q4 2020
Shares
1.53M
% of Portfolio
+0.50%
Quarters Held
9
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $84MQ4 ’18Q1 ’19: $98MQ2 ’19: $110MQ2 ’19Q3 ’19: $114MQ4 ’19: $119MQ4 ’19Q1 ’20: $113MQ2 ’20: $134MQ2 ’20Q3 ’20: $164MQ4 ’20: $168MQ4 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20201.53M$168M+0.50%
Q3 20201.51M$164M+0.55%
Q2 20201.47M$134M+0.50%
Q1 20201.43M$113M+0.50%
Q4 20191.37M$119M+0.43%
Q3 20191.36M$114M+0.45%
Q2 20191.31M$110M+0.45%
Q1 20191.23M$98M+0.42%
Q4 20181.16M$84M+0.42%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Aperio Group, LLC’s full portfolio or all institutional holders of ABT.